PEGS Boston 2021 Recap Series Recap Series Wrap Up - PEGS Boston 2021 We very much enjoyed attending, presenting and networking at PEGS Boston virtual conference and we look forward to an in-person event next year. We tried to make it to as many talks as we could, and were impressed by the achievements [...]
PEGS Boston 2021 Recap Series Aids and Cancer Antibody Engineering, Support from REmAb® Sequencing Our core sequencing platform, REmAb®, is a mass spectrometry-based de novo protein sequencing platform. Our clients routinely use REmAb® because they can access the primary amino acid sequence of a monoclonal antibody (mAb) protein sample from any species, no matter [...]
PEGS Boston 2021 Recap Series Rapid Novor Continues to Empower Researchers through Protein Sequencing Advances With some exciting news to share, we were eager to present about how our company is advancing antibody discovery thanks to our next generation protein sequencing at the PEGS Summit last week. And it seems that many people were [...]
PEGS Boston 2021 Recap Series Decoding the Immune Response In today’s RECAP: PEGS Boston 2021 series, we discuss the importance of tracking the immune response to therapies and treatments by highlighting Dr. Tovey’s amazing talk on gene therapeutic AAV vectors, and our protein sequencing technology efforts: NovorIg and EasyM. Quantification of the Neutralizing Antibody [...]
PEGS Boston 2021 Recap Series Structure Knowledge is Vital for Design and Development of Better Therapeutics In today’s RECAP: PEGS Boston 2021 series, we discuss Dr. Olga Ab’s talk on an important class of therapeutics in the fight against cancer, and highlight why Rapid Novor seeks to empower scientists with full antibody protein sequences. [...]
PEGS Boston 2021 Recap Series Decoding the Immune Response In today’s RECAP: PEGS Boston 2021 series, we discuss the importance of tracking the immune response to therapies and treatments by highlighting Dr. Tovey’s amazing talk on gene therapeutic AAV vectors, and our protein sequencing technology efforts: NovorIg and EasyM. Quantification of the Neutralizing Antibody [...]
PEGS Boston 2021 Recap Series Dreaming about the integration between our Next Generation Protein Sequencing Platform and de novo Protein Design At the 17th PEGS Boston conference held virtually last week, hundreds of speakers from both academia and industry worldwide shared their latest research and developments in the field of protein engineering and cell [...]
We can’t wait to check out these talks at PEGS Boston 2021! Another year has rolled by and we find ourselves at PEGS Boston again! Rapid Novor will be participating this year as well, with a talk entitled “Landing on the Moon with Mass Spectrometry: Polyclonal Sequencing with Only Proteomics.” Our very own Director [...]